We suggest that ZIP6 and ZIP10 may be candidate markers for metastatic spread in hyperglycemia with diabetes, although molecular mechanisms of studies will be required further, and it is proposed that analyses of high glucose-induced cell migration provide novel strategies for the diagnosis and therapy of breast cancer with hyperglycemia. Here, SLC39A6 is linked to breast cancer.